Email your MP: Help us improve access to life-extending drugs

Make sure your MP joins us in parliament to find out how they can help fix the system for deciding which drugs are made available on the NHS in England.

Send them a quick email today

Ask them to attend the launch of our new report: "Setting the bar too high: How the NICE severity modifier is blocking access to life-extending treatments". It's a chance for them to find out what’s wrong with the system and how they can help us fix it.

It'll only take a minutue!

All you need to do is enter your details and click "EMAIL MY MP" to send a pre-written invitation to your MP. They’re much more likely to come if they’re invited by you, one of their constituents. 

• What's the problem?

  We want people living with incurable secondary breast cancer to be able to access drugs that can give them more time to live.

  But under the current system, they aren’t always able to. That’s because their condition sometimes isn’t considered severe enough, so the NHS won’t pay as much for their treatments as they used to. This is despite some of them having only months to live.

  The drug Enhertu for HER2-low secondary breast cancer has already been rejected for use on the NHS. And we don’t think it will be the last.

  The system urgently needs to change. People living with incurable secondary breast cancer don't have time to wait. Take action

• What about Wales, Northern Ireland and Scotland?

  In England, the organisation that decides whether drugs can be made available on the NHS is the National Institute for Health and Care Excellence, usually known as NICE.

  They make recommendations that apply in England, but these decisions are usually adopted by Wales and Northern Ireland - so fixing the system matters here too.

  Scotland makes their own decisions through their equivalent of NICE, the Scottish Medicines Consortium (SMC).

  Take action